Cardiac inflammation, a condition characterized by inflammation of the heart tissue, plays a significant role in various cardiovascular diseases. This inflammatory response can be triggered by infections, autoimmune disorders, or other underlying health issues. When the heart becomes inflamed, it may lead to serious complications, affecting the organ's ability to pump blood effectively. Conditions such as myocarditis and pericarditis are common manifestations of cardiac inflammation, posing risks of heart failure if left untreated. Researchers and healthcare professionals are actively exploring the intricate mechanisms of cardiac inflammation to develop targeted interventions and preventive measures. Understanding and addressing cardiac inflammation are crucial steps in advancing cardiovascular health and mitigating the impact of related diseases on individuals worldwide.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India